Orally Disintegrating Tablet Excipient Industry Research Report 2023

Orally Disintegrating Tablet Excipient Industry Research Report 2023


An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.

Highlights

The global Orally Disintegrating Tablet Excipient market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Tablet Excipient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Tablet Excipient.
The Orally Disintegrating Tablet Excipient market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Orally Disintegrating Tablet Excipient market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Disintegrating Tablet Excipient manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

BASF
JRS Pharma
Roquette
ABF Ingredients
DFE Pharma
Evonik
Merck KGaA
Ashland
Meggle Pharma
Shin-Etsu
Fuji Chemical Industries
McePharma (Vivesa holding)
Cargill Incorporated
Daicel Corporation
Anhui Sunhere Pharmaceutical

Product Type Insights

Global markets are presented by Orally Disintegrating Tablet Excipient type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Orally Disintegrating Tablet Excipient are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Orally Disintegrating Tablet Excipient segment by Type

Binders
Glidents
Diluents
Disintegrants
Others

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Orally Disintegrating Tablet Excipient market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Orally Disintegrating Tablet Excipient market.
Orally Disintegrating Tablet Excipient segment by Application

Anti-Psychotics Drug
Anti-Epileptics Drug
Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Orally Disintegrating Tablet Excipient market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orally Disintegrating Tablet Excipient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Orally Disintegrating Tablet Excipient and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Orally Disintegrating Tablet Excipient industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orally Disintegrating Tablet Excipient.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Orally Disintegrating Tablet Excipient manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Orally Disintegrating Tablet Excipient by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Orally Disintegrating Tablet Excipient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Frequently Asked Questions

Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Orally Disintegrating Tablet Excipient Market Size (2018-2029) & (US$ Million)
2.2.2 Global Orally Disintegrating Tablet Excipient Sales (2018-2029)
2.2.3 Global Orally Disintegrating Tablet Excipient Market Average Price (2018-2029)
2.3 Orally Disintegrating Tablet Excipient by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Binders
1.2.3 Glidents
1.2.4 Diluents
1.2.5 Disintegrants
1.2.6 Others
2.4 Orally Disintegrating Tablet Excipient by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Anti-Psychotics Drug
2.4.3 Anti-Epileptics Drug
2.4.4 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Orally Disintegrating Tablet Excipient Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Orally Disintegrating Tablet Excipient Sales (K MT) of Manufacturers (2018-2023)
3.3 Global Orally Disintegrating Tablet Excipient Revenue of Manufacturers (2018-2023)
3.4 Global Orally Disintegrating Tablet Excipient Average Price by Manufacturers (2018-2023)
3.5 Global Orally Disintegrating Tablet Excipient Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Orally Disintegrating Tablet Excipient, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Orally Disintegrating Tablet Excipient, Product Type & Application
3.8 Global Manufacturers of Orally Disintegrating Tablet Excipient, Date of Enter into This Industry
3.9 Global Orally Disintegrating Tablet Excipient Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 BASF
4.1.1 BASF Company Information
4.1.2 BASF Business Overview
4.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2023)
4.1.4 BASF Orally Disintegrating Tablet Excipient Product Portfolio
4.1.5 BASF Recent Developments
4.2 JRS Pharma
4.2.1 JRS Pharma Company Information
4.2.2 JRS Pharma Business Overview
4.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2023)
4.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Product Portfolio
4.2.5 JRS Pharma Recent Developments
4.3 Roquette
4.3.1 Roquette Company Information
4.3.2 Roquette Business Overview
4.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Roquette Orally Disintegrating Tablet Excipient Product Portfolio
4.3.5 Roquette Recent Developments
4.4 ABF Ingredients
4.4.1 ABF Ingredients Company Information
4.4.2 ABF Ingredients Business Overview
4.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2023)
4.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Product Portfolio
4.4.5 ABF Ingredients Recent Developments
4.5 DFE Pharma
4.5.1 DFE Pharma Company Information
4.5.2 DFE Pharma Business Overview
4.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2023)
6.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Product Portfolio
6.5.5 DFE Pharma Recent Developments
4.6 Evonik
4.6.1 Evonik Company Information
4.6.2 Evonik Business Overview
4.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Evonik Orally Disintegrating Tablet Excipient Product Portfolio
4.6.5 Evonik Recent Developments
4.7 Merck KGaA
4.7.1 Merck KGaA Company Information
4.7.2 Merck KGaA Business Overview
4.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Product Portfolio
4.7.5 Merck KGaA Recent Developments
6.8 Ashland
4.8.1 Ashland Company Information
4.8.2 Ashland Business Overview
4.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Ashland Orally Disintegrating Tablet Excipient Product Portfolio
4.8.5 Ashland Recent Developments
4.9 Meggle Pharma
4.9.1 Meggle Pharma Company Information
4.9.2 Meggle Pharma Business Overview
4.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Product Portfolio
4.9.5 Meggle Pharma Recent Developments
4.10 Shin-Etsu
4.10.1 Shin-Etsu Company Information
4.10.2 Shin-Etsu Business Overview
4.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Product Portfolio
4.10.5 Shin-Etsu Recent Developments
6.11 Fuji Chemical Industries
6.11.1 Fuji Chemical Industries Company Information
6.11.2 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Business Overview
6.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Portfolio
6.11.5 Fuji Chemical Industries Recent Developments
6.12 McePharma (Vivesa holding)
6.12.1 McePharma (Vivesa holding) Company Information
6.12.2 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Business Overview
6.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2023)
6.12.4 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Portfolio
6.12.5 McePharma (Vivesa holding) Recent Developments
6.13 Cargill Incorporated
6.13.1 Cargill Incorporated Company Information
6.13.2 Cargill Incorporated Orally Disintegrating Tablet Excipient Business Overview
6.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Cargill Incorporated Orally Disintegrating Tablet Excipient Product Portfolio
6.13.5 Cargill Incorporated Recent Developments
6.14 Daicel Corporation
6.14.1 Daicel Corporation Company Information
6.14.2 Daicel Corporation Orally Disintegrating Tablet Excipient Business Overview
6.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Daicel Corporation Orally Disintegrating Tablet Excipient Product Portfolio
6.14.5 Daicel Corporation Recent Developments
6.15 Anhui Sunhere Pharmaceutical
6.15.1 Anhui Sunhere Pharmaceutical Company Information
6.15.2 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Business Overview
6.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Portfolio
6.15.5 Anhui Sunhere Pharmaceutical Recent Developments
5 Global Orally Disintegrating Tablet Excipient Market Scenario by Region
5.1 Global Orally Disintegrating Tablet Excipient Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Orally Disintegrating Tablet Excipient Sales by Region: 2018-2029
5.2.1 Global Orally Disintegrating Tablet Excipient Sales by Region: 2018-2023
5.2.2 Global Orally Disintegrating Tablet Excipient Sales by Region: 2024-2029
5.3 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2018-2029
5.3.1 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2018-2023
5.3.2 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2024-2029
5.4 North America Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
5.4.1 North America Orally Disintegrating Tablet Excipient Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Orally Disintegrating Tablet Excipient Sales by Country (2018-2029)
5.4.3 North America Orally Disintegrating Tablet Excipient Revenue by Country (2018-2029)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
5.5.1 Europe Orally Disintegrating Tablet Excipient Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Orally Disintegrating Tablet Excipient Sales by Country (2018-2029)
5.5.3 Europe Orally Disintegrating Tablet Excipient Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
5.6.1 Asia Pacific Orally Disintegrating Tablet Excipient Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Orally Disintegrating Tablet Excipient Sales by Country (2018-2029)
5.6.3 Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
5.7.1 Latin America Orally Disintegrating Tablet Excipient Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Orally Disintegrating Tablet Excipient Sales by Country (2018-2029)
5.7.3 Latin America Orally Disintegrating Tablet Excipient Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
5.8.1 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2018-2029)
5.8.3 Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2018-2029)
6.1.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2018-2029) & (K MT)
6.1.2 Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2018-2029)
6.2 Global Orally Disintegrating Tablet Excipient Revenue by Type (2018-2029)
6.2.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2018-2029)
6.3 Global Orally Disintegrating Tablet Excipient Price by Type (2018-2029)
7 Segment by Application
7.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2018-2029)
7.1.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2018-2029) & (K MT)
7.1.2 Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2018-2029)
7.2 Global Orally Disintegrating Tablet Excipient Revenue by Application (2018-2029)
6.2.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2018-2029)
7.3 Global Orally Disintegrating Tablet Excipient Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Orally Disintegrating Tablet Excipient Value Chain Analysis
8.1.1 Orally Disintegrating Tablet Excipient Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Orally Disintegrating Tablet Excipient Production Mode & Process
8.2 Orally Disintegrating Tablet Excipient Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Orally Disintegrating Tablet Excipient Distributors
8.2.3 Orally Disintegrating Tablet Excipient Customers
9 Global Orally Disintegrating Tablet Excipient Analyzing Market Dynamics
9.1 Orally Disintegrating Tablet Excipient Industry Trends
9.2 Orally Disintegrating Tablet Excipient Industry Drivers
9.3 Orally Disintegrating Tablet Excipient Industry Opportunities and Challenges
9.4 Orally Disintegrating Tablet Excipient Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Orally Disintegrating Tablet Excipient Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Orally Disintegrating Tablet Excipient Sales (K MT) of Manufacturers (2018-2023)
Table 7. Global Orally Disintegrating Tablet Excipient Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Orally Disintegrating Tablet Excipient Revenue of Manufacturers (2018-2023)
Table 9. Global Orally Disintegrating Tablet Excipient Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Orally Disintegrating Tablet Excipient Average Price (USD/MT) of Manufacturers (2018-2023)
Table 11. Global Orally Disintegrating Tablet Excipient Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Orally Disintegrating Tablet Excipient, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Orally Disintegrating Tablet Excipient by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. BASF Company Information
Table 17. BASF Business Overview
Table 18. BASF Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 19. BASF Orally Disintegrating Tablet Excipient Product Portfolio
Table 20. BASF Recent Developments
Table 21. JRS Pharma Company Information
Table 22. JRS Pharma Business Overview
Table 23. JRS Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 24. JRS Pharma Orally Disintegrating Tablet Excipient Product Portfolio
Table 25. JRS Pharma Recent Developments
Table 26. Roquette Company Information
Table 27. Roquette Business Overview
Table 28. Roquette Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 29. Roquette Orally Disintegrating Tablet Excipient Product Portfolio
Table 30. Roquette Recent Developments
Table 31. ABF Ingredients Company Information
Table 32. ABF Ingredients Business Overview
Table 33. ABF Ingredients Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 34. ABF Ingredients Orally Disintegrating Tablet Excipient Product Portfolio
Table 35. ABF Ingredients Recent Developments
Table 36. DFE Pharma Company Information
Table 37. DFE Pharma Business Overview
Table 38. DFE Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 39. DFE Pharma Orally Disintegrating Tablet Excipient Product Portfolio
Table 40. DFE Pharma Recent Developments
Table 41. Evonik Company Information
Table 42. Evonik Business Overview
Table 43. Evonik Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 44. Evonik Orally Disintegrating Tablet Excipient Product Portfolio
Table 45. Evonik Recent Developments
Table 46. Merck KGaA Company Information
Table 47. Merck KGaA Business Overview
Table 48. Merck KGaA Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 49. Merck KGaA Orally Disintegrating Tablet Excipient Product Portfolio
Table 50. Merck KGaA Recent Developments
Table 51. Ashland Company Information
Table 52. Ashland Business Overview
Table 53. Ashland Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 54. Ashland Orally Disintegrating Tablet Excipient Product Portfolio
Table 55. Ashland Recent Developments
Table 56. Meggle Pharma Company Information
Table 57. Meggle Pharma Business Overview
Table 58. Meggle Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. Meggle Pharma Orally Disintegrating Tablet Excipient Product Portfolio
Table 60. Meggle Pharma Recent Developments
Table 61. Shin-Etsu Company Information
Table 62. Shin-Etsu Business Overview
Table 63. Shin-Etsu Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 64. Shin-Etsu Orally Disintegrating Tablet Excipient Product Portfolio
Table 65. Shin-Etsu Recent Developments
Table 66. Fuji Chemical Industries Company Information
Table 67. Fuji Chemical Industries Business Overview
Table 68. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 69. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Portfolio
Table 70. Fuji Chemical Industries Recent Developments
Table 71. McePharma (Vivesa holding) Company Information
Table 72. McePharma (Vivesa holding) Business Overview
Table 73. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 74. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Portfolio
Table 75. McePharma (Vivesa holding) Recent Developments
Table 76. Cargill Incorporated Company Information
Table 77. Cargill Incorporated Business Overview
Table 78. Cargill Incorporated Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 79. Cargill Incorporated Orally Disintegrating Tablet Excipient Product Portfolio
Table 80. Cargill Incorporated Recent Developments
Table 81. Daicel Corporation Company Information
Table 82. Daicel Corporation Business Overview
Table 83. Daicel Corporation Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 84. Daicel Corporation Orally Disintegrating Tablet Excipient Product Portfolio
Table 85. Daicel Corporation Recent Developments
Table 86. Anhui Sunhere Pharmaceutical Company Information
Table 87. Anhui Sunhere Pharmaceutical Business Overview
Table 88. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 89. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Portfolio
Table 90. Anhui Sunhere Pharmaceutical Recent Developments
Table 91. Global Orally Disintegrating Tablet Excipient Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 92. Global Orally Disintegrating Tablet Excipient Sales by Region (2018-2023) & (K MT)
Table 93. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2018-2023)
Table 94. Global Orally Disintegrating Tablet Excipient Sales by Region (2024-2029) & (K MT)
Table 95. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2024-2029)
Table 96. Global Orally Disintegrating Tablet Excipient Revenue by Region (2018-2023) & (US$ Million)
Table 97. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2018-2023)
Table 98. Global Orally Disintegrating Tablet Excipient Revenue by Region (2024-2029) & (US$ Million)
Table 99. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2024-2029)
Table 100. North America Orally Disintegrating Tablet Excipient Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. North America Orally Disintegrating Tablet Excipient Sales by Country (2018-2023) & (K MT)
Table 102. North America Orally Disintegrating Tablet Excipient Sales by Country (2024-2029) & (K MT)
Table 103. North America Orally Disintegrating Tablet Excipient Revenue by Country (2018-2023) & (US$ Million)
Table 104. North America Orally Disintegrating Tablet Excipient Revenue by Country (2024-2029) & (US$ Million)
Table 105. Europe Orally Disintegrating Tablet Excipient Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Europe Orally Disintegrating Tablet Excipient Sales by Country (2018-2023) & (K MT)
Table 107. Europe Orally Disintegrating Tablet Excipient Sales by Country (2024-2029) & (K MT)
Table 108. Europe Orally Disintegrating Tablet Excipient Revenue by Country (2018-2023) & (US$ Million)
Table 109. Europe Orally Disintegrating Tablet Excipient Revenue by Country (2024-2029) & (US$ Million)
Table 110. Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Country (2018-2023) & (K MT)
Table 112. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Country (2024-2029) & (K MT)
Table 113. Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Country (2018-2023) & (US$ Million)
Table 114. Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Country (2024-2029) & (US$ Million)
Table 115. Latin America Orally Disintegrating Tablet Excipient Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Latin America Orally Disintegrating Tablet Excipient Sales by Country (2018-2023) & (K MT)
Table 117. Latin America Orally Disintegrating Tablet Excipient Sales by Country (2024-2029) & (K MT)
Table 118. Latin America Orally Disintegrating Tablet Excipient Revenue by Country (2018-2023) & (US$ Million)
Table 119. Latin America Orally Disintegrating Tablet Excipient Revenue by Country (2024-2029) & (US$ Million)
Table 120. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2018-2023) & (K MT)
Table 122. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2024-2029) & (K MT)
Table 123. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2018-2023) & (US$ Million)
Table 124. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2024-2029) & (US$ Million)
Table 125. Global Orally Disintegrating Tablet Excipient Sales by Type (2018-2023) & (K MT)
Table 126. Global Orally Disintegrating Tablet Excipient Sales by Type (2024-2029) & (K MT)
Table 127. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2018-2023)
Table 128. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2024-2029)
Table 129. Global Orally Disintegrating Tablet Excipient Revenue by Type (2018-2023) & (US$ Million)
Table 130. Global Orally Disintegrating Tablet Excipient Revenue by Type (2024-2029) & (US$ Million)
Table 131. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2018-2023)
Table 132. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2024-2029)
Table 133. Global Orally Disintegrating Tablet Excipient Price by Type (2018-2023) & (USD/MT)
Table 134. Global Orally Disintegrating Tablet Excipient Price by Type (2024-2029) & (USD/MT)
Table 135. Global Orally Disintegrating Tablet Excipient Sales by Application (2018-2023) & (K MT)
Table 136. Global Orally Disintegrating Tablet Excipient Sales by Application (2024-2029) & (K MT)
Table 137. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2018-2023)
Table 138. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2024-2029)
Table 139. Global Orally Disintegrating Tablet Excipient Revenue by Application (2018-2023) & (US$ Million)
Table 140. Global Orally Disintegrating Tablet Excipient Revenue by Application (2024-2029) & (US$ Million)
Table 141. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2018-2023)
Table 142. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2024-2029)
Table 143. Global Orally Disintegrating Tablet Excipient Price by Application (2018-2023) & (USD/MT)
Table 144. Global Orally Disintegrating Tablet Excipient Price by Application (2024-2029) & (USD/MT)
Table 145. Key Raw Materials
Table 146. Raw Materials Key Suppliers
Table 147. Orally Disintegrating Tablet Excipient Distributors List
Table 148. Orally Disintegrating Tablet Excipient Customers List
Table 149. Orally Disintegrating Tablet Excipient Industry Trends
Table 150. Orally Disintegrating Tablet Excipient Industry Drivers
Table 151. Orally Disintegrating Tablet Excipient Industry Restraints
Table 152. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Orally Disintegrating Tablet ExcipientProduct Picture
Figure 5. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Orally Disintegrating Tablet Excipient Market Size (2018-2029) & (US$ Million)
Figure 7. Global Orally Disintegrating Tablet Excipient Sales (2018-2029) & (K MT)
Figure 8. Global Orally Disintegrating Tablet Excipient Average Price (USD/MT) & (2018-2029)
Figure 9. Binders Product Picture
Figure 10. Glidents Product Picture
Figure 11. Diluents Product Picture
Figure 12. Disintegrants Product Picture
Figure 13. Others Product Picture
Figure 14. Anti-Psychotics Drug Product Picture
Figure 15. Anti-Epileptics Drug Product Picture
Figure 16. Others Product Picture
Figure 17. Global Orally Disintegrating Tablet Excipient Revenue Share by Manufacturers in 2022
Figure 18. Global Manufacturers of Orally Disintegrating Tablet Excipient, Manufacturing Sites & Headquarters
Figure 19. Global Manufacturers of Orally Disintegrating Tablet Excipient, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 Orally Disintegrating Tablet Excipient Players Market Share by Revenue in 2022
Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. Global Orally Disintegrating Tablet Excipient Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. Global Orally Disintegrating Tablet Excipient Sales by Region in 2022
Figure 24. Global Orally Disintegrating Tablet Excipient Revenue by Region in 2022
Figure 25. North America Orally Disintegrating Tablet Excipient Market Size by Country in 2022
Figure 26. North America Orally Disintegrating Tablet Excipient Sales Market Share by Country (2018-2029)
Figure 27. North America Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2018-2029)
Figure 28. U.S. Orally Disintegrating Tablet Excipient Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Canada Orally Disintegrating Tablet Excipient Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Europe Orally Disintegrating Tablet Excipient Market Size by Country in 2022
Figure 31. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Country (2018-2029)
Figure 32. Europe Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2018-2029)
Figure 33. Germany Orally Disintegrating Tablet Excipient Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. France Orally Disintegrating Tablet Excipient Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. U.K. Orally Disintegrating Tablet Excipient Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Italy Orally Disintegrating Tablet Excipient Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Russia Orally Disintegrating Tablet Excipient Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Asia Pacific Orally Disintegrating Tablet Excipient Market Size by Country in 2022
Figure 39. Asia Pacific Orally Disintegrating Tablet Excipient Sales Market Share by Country (2018-2029)
Figure 40. Asia Pacific Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2018-2029)
Figure 41. China Orally Disintegrating Tablet Excipient Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Japan Orally Disintegrating Tablet Excipient Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. South Korea Orally Disintegrating Tablet Excipient Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. India Orally Disintegrating Tablet Excipient Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Australia Orally Disintegrating Tablet Excipient Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. China Taiwan Orally Disintegrating Tablet Excipient Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Indonesia Orally Disintegrating Tablet Excipient Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Thailand Orally Disintegrating Tablet Excipient Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Malaysia Orally Disintegrating Tablet Excipient Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Latin America Orally Disintegrating Tablet Excipient Market Size by Country in 2022
Figure 51. Latin America Orally Disintegrating Tablet Excipient Sales Market Share by Country (2018-2029)
Figure 52. Latin America Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2018-2029)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings